Lyng H - Search Results

1

A prognostic hypoxia gene signature with low heterogeneity within the dominant tumour lesion in prostate cancer patients.

Salberg UB, Skingen VE, Fjeldbo CS, Hompland T, Ragnum HB, Vlatkovic L, Hole KH, Seierstad T, Lyng H. Salberg UB, et al. Among authors: lyng h. Br J Cancer. 2022 Jul;127(2):321-328. doi: 10.1038/s41416-022-01782-x. Epub 2022 Mar 24. Br J Cancer. 2022. PMID: 35332267 Free PMC article.

2

Hypoxia-induced tetraploidisation of a diploid human melanoma cell line in vitro.

Rofstad EK, Johnsen NM, Lyng H. Rofstad EK, et al. Among authors: lyng h. Br J Cancer Suppl. 1996 Jul;27:S136-9. Br J Cancer Suppl. 1996. PMID: 8763866 Free PMC article.

3

Oxygen tension and vascular density in human cervix carcinoma.

Lyng H, Sundfør K, Tropé C, Rofstad EK. Lyng H, et al. Br J Cancer. 1996 Nov;74(10):1559-63. doi: 10.1038/bjc.1996.589. Br J Cancer. 1996. PMID: 8932335 Free PMC article.

4

Tumour hypoxia and vascular density as predictors of metastasis in squamous cell carcinoma of the uterine cervix.

Sundfør K, Lyng H, Rofstad EK. Sundfør K, et al. Among authors: lyng h. Br J Cancer. 1998 Sep;78(6):822-7. doi: 10.1038/bjc.1998.586. Br J Cancer. 1998. PMID: 9743308 Free PMC article.

5

Hypoxia-induced treatment failure in advanced squamous cell carcinoma of the uterine cervix is primarily due to hypoxia-induced radiation resistance rather than hypoxia-induced metastasis.

Rofstad EK, Sundfør K, Lyng H, Tropé CG. Rofstad EK, et al. Among authors: lyng h. Br J Cancer. 2000 Aug;83(3):354-9. doi: 10.1054/bjoc.2000.1266. Br J Cancer. 2000. PMID: 10917551 Free PMC article.

6

Membranous expression of ectodomain isoforms of the epidermal growth factor receptor predicts outcome after chemoradiotherapy of lymph node-negative cervical cancer.

Halle C, Lando M, Svendsrud DH, Clancy T, Holden M, Sundfør K, Kristensen GB, Holm R, Lyng H. Halle C, et al. Among authors: lyng h. Clin Cancer Res. 2011 Aug 15;17(16):5501-12. doi: 10.1158/1078-0432.CCR-11-0297. Epub 2011 Jul 7. Clin Cancer Res. 2011. PMID: 21737508

7

Dynamic contrast-enhanced MRI of cervical cancers: temporal percentile screening of contrast enhancement identifies parameters for prediction of chemoradioresistance.

Andersen EK, Hole KH, Lund KV, Sundfør K, Kristensen GB, Lyng H, Malinen E. Andersen EK, et al. Among authors: lyng h. Int J Radiat Oncol Biol Phys. 2012 Mar 1;82(3):e485-92. doi: 10.1016/j.ijrobp.2011.05.050. Epub 2011 Oct 17. Int J Radiat Oncol Biol Phys. 2012. PMID: 22014954

8

Vascular responses to radiotherapy and androgen-deprivation therapy in experimental prostate cancer.

Røe K, Mikalsen LT, van der Kogel AJ, Bussink J, Lyng H, Ree AH, Marignol L, Olsen DR. Røe K, et al. Among authors: lyng h. Radiat Oncol. 2012 May 23;7:75. doi: 10.1186/1748-717X-7-75. Radiat Oncol. 2012. PMID: 22621752 Free PMC article.

9

Hypoxia-induced gene expression in chemoradioresistant cervical cancer revealed by dynamic contrast-enhanced MRI.

Halle C, Andersen E, Lando M, Aarnes EK, Hasvold G, Holden M, Syljuåsen RG, Sundfør K, Kristensen GB, Holm R, Malinen E, Lyng H. Halle C, et al. Among authors: lyng h. Cancer Res. 2012 Oct 15;72(20):5285-95. doi: 10.1158/0008-5472.CAN-12-1085. Epub 2012 Aug 13. Cancer Res. 2012. PMID: 22890239

10

Pharmacokinetic parameters derived from dynamic contrast enhanced MRI of cervical cancers predict chemoradiotherapy outcome.

Andersen EK, Hole KH, Lund KV, Sundfør K, Kristensen GB, Lyng H, Malinen E. Andersen EK, et al. Among authors: lyng h. Radiother Oncol. 2013 Apr;107(1):117-22. doi: 10.1016/j.radonc.2012.11.007. Epub 2013 Jan 17. Radiother Oncol. 2013. PMID: 23333024

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

130 results

Search Page

Filters